Atopic Dermatitis
Dosage in Adults :
Dosage in Pediatric Patients 6 Months to 5 Years of Age :
Body Weight | Initial and Subsequent Dosage |
---|---|
5 to less than 15 kg | 200 mg (one 200 mg injection) every 4 weeks (Q4W) |
15 to less than 30 kg | 300 mg (one 300 mg injection) every 4 weeks (Q4W) |
Dosage in Pediatric Patients 6 Years to 17 Years of Age :
Body Weight | Initial Loading Dose | Subsequent Dosage * |
---|---|---|
15 to less than 30 kg | 600 mg (two 300 mg injections) | 300 mg Q4W |
30 to less than 60 kg | 400 mg (two 200 mg injections) | 200 mg Q2W |
60 kg or more | 600 mg (two 300 mg injections) | 300 mg Q2W |
Asthma
Dosage in Adult and Pediatric Patients 12 Years and Older :
Initial Loading Dose | Subsequent Dosage |
---|---|
400 mg (two 200 mg injections) | 200 mg every 2 weeks (Q2W) |
or | |
600 mg (two 300 mg injections) | 300 mg every 2 weeks (Q2W) |
Dosage for patients with oral corticosteroid-dependent asthma or with co-morbid moderate-to-severe atopic dermatitis or adults with co-morbid chronic rhinosinusitis with nasal polyposis | |
600 mg (two 300 mg injections) | 300 mg every 2 weeks (Q2W) |
Dosage in Pediatric Patients 6 to 11 Years of Age :
Body Weight | Initial Dose and Subsequent Dosage |
---|---|
15 to less than 30 kg | 100 mg every other week (Q2W) or 300 mg every four weeks (Q4W) |
≥30 kg | 200 mg every other week (Q2W) |
For pediatric patients 6 to 11 years old with asthma and co-morbid moderate-to-severe atopic dermatitis, follow the recommended dosage as per Table 2 which includes an initial loading dose.
Chronic Rhinosinusitis with Nasal Polyposis :
Eosinophilic Esophagitis :
Prurigo Nodularis :